Cargando…
The King’s Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference
INTRODUCTION: The King’s Brief Interstitial Lung Disease (KBILD) is a 15-item validated health-related quality of life (HRQOL) questionnaire. The method of scoring the KBILD has recently changed to incorporate a logit-scale transformation from one that used raw item responses, as this is potentially...
Autores principales: | Sinha, Aish, Patel, Amit Suresh, Siegert, Richard J, Bajwah, Sabrina, Maher, Toby M, Renzoni, Elizabeth A, Wells, Athol U, Higginson, Irene J, Birring, Surinder S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424243/ https://www.ncbi.nlm.nih.gov/pubmed/30956799 http://dx.doi.org/10.1136/bmjresp-2018-000363 |
Ejemplares similares
-
Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017) -
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
por: Flaherty, Kevin R, et al.
Publicado: (2017) -
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial
por: Maher, Toby M, et al.
Publicado: (2018) -
Physical Inactivity in Pulmonary Sarcoidosis
por: Cho, Peter S. P., et al.
Publicado: (2019) -
Analytic Morphomics in Myositis-Related Interstitial Lung Disease
por: O’Mahony, Alexander T., et al.
Publicado: (2023)